Sort   by:  
 Page size 
Cryopreserved normal CD34 + bone marrow cells were derived from eight healthy Caucasians (four men and four women; PromoCell GMBH; Heidelberg, Germany), and their age did not differ significantly from the AML patients analysed in the study. The submitted samples have been analyzed together with raw ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD058846 | Pride
In the current study, we have studied the effect of three storage and preparation protocols on two AML-derived cell lines: 1) cryopreservation of viable cells for storage in liquid nitrogen, 2) cell pellet storage in liquid nitrogen and 3) freshly SDS lysed cell lysate stored at -°80. We further stu...
ORGANISM(S): Homo sapiens (Human) 
2018-01-19 | PXD008361 | Pride
The main objective of this study was to evaluate the protein expression profiling of serum and lungs at different stages of metastatic development in a human triple negative MDA-MB
ORGANISM(S): Mus musculus (Mouse) 
2019-05-07 | PXD010249 | Pride
The main objective of this study was to evaluate the protein expression profiling of serum and lungs at different stages of metastatic development in a human triple negative MDA-MB
ORGANISM(S): Mus musculus (Mouse) 
2019-05-07 | PXD010248 | Pride
Patients diagnosed with glioblastoma (GBM) with sustained synthesis of the DNA repair enzyme, O6-methyl guanine DNA methytransferase (MGMT), are rendered resistant to Temozolomide (TMZ) chemotherapy. Here, we hypothesized that pretreatment with the proteasome inhibitor Bortezomib (BTZ, Velcade) migh...
ORGANISM(S): Mus musculus (Mouse) 
2019-08-20 | PXD007193 | Pride
ABSTRACT FOR BOTH PLASMA AND PLATELET-LYSATE In this article we describe the involvement of exchange factor activated by cAMP 1 (Epac1) in hemostasis and platelet activation. We have used plasma and platelet-lysate from EPAC1 knockout mice and wild-type control mice in label-free proteomics with an ...
ORGANISM(S): Mus musculus (Mouse) 
2017-07-25 | PXD000282 | Pride
LC-MS/MS raw files of proteomics, phosphoproteomics and pTyr-proteomics from patients with high and low risk of adverse AML
ORGANISM(S): Homo sapiens (Human) 
2021-01-04 | PXD019785 | Pride
MS-based proteomics and phosphoproteomics study based on 7 paired diagnosis-first relapse AML patient samples
ORGANISM(S): Homo sapiens (Human) 
2020-06-12 | PXD018359 | Pride
We evaluated different in-solution and filter-aided sample preparation (FASP) proteomic workflows, and different enrichment strategies of phosphorylated peptides on acute myeloid leukemia (AML) patient samples. We also studied the effect of liquid nitrogen storage on the proteome and phosphoproteome...
ORGANISM(S): Homo sapiens (Human) 
2016-04-26 | PXD003822 | Pride
As a direct consequence of the high diversity of the aggressive blood cancer acute myeloid leukemia (AML), proteomic samples from patients are strongly heterogeneous, rendering their accurate relative quantification challenging. In the present study, we investigated the benefits of using a super-SI...
ORGANISM(S): Homo sapiens (Human) 
2014-07-15 | PXD000441 | Pride
Sort   by:  
 Page size